22 studies found for:    " April 20, 2011":" May 20, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" April 20, 2011":" May 20, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth
Conditions: Patient Adherence;   HIV
Intervention: Behavioral: SMS Text Message Reminder
2 Recruiting Treatment Advocacy Intervention for HIV-Positive African Americans
Condition: HIV
Intervention: Behavioral: Treatment Advocacy
3 Active, not recruiting Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: EVG/COBI/FTC/TDF;   Drug: COBI;   Drug: ATV;   Drug: DRV;   Drug: NRTI
4 Completed A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients
Condition: Human Immunodeficiency Virus (HIV) Infection
Intervention: Drug: Etravirine
5 Completed Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023
Condition: Human Immunodeficiency Virus
Interventions: Drug: KM-023;   Drug: Placebo for KM-023
6 Active, not recruiting Switch to Unboosted Atazanavir With Tenofovir Study
Condition: HIV Infection
Interventions: Drug: atazanavir;   Drug: atazanavir/ritonavir
7 Recruiting Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
Conditions: Hepatitis;   HIV;   Liver Cancer
Intervention:
8 Completed Text Messaging Intervention to Improve HIV Adherence in Rural Drug Users
Condition: HIV Infections
Interventions: Behavioral: Text messaging plus EMA;   Behavioral: Treatment as usual
9 Completed Study to Assess the Seroprevalence of Anti-Tat Antibodies in HIV-infected Patients
Condition: HIV Infection
Intervention:
10 Recruiting Traditional Complementary and Alternative Medicine (CAM) Therapy in the Treatment of HIV/AIDS
Condition: HIV Infections
Intervention: Drug: "Kallunk oxide (Immunotherapy) "
11 Completed Dolutegravir Renal Impairment Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Dolutegravir 50 mg
12 Unknown  Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection
Condition: HIV
Interventions: Drug: atripla;   Drug: darunavir ritonavir raltegravir
13 Active, not recruiting Human Immune Responses Toward HIV-1 Envelope Antigens
Condition: HIV Infection
Intervention:
14 Active, not recruiting Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China
Conditions: HIV Infections;   Central Nervous System Diseases;   Dementia
Interventions: Drug: zidovudine-lamivudine-nevirapine;   Drug: tenofovir-lamivudine-efavirenz
15 Completed Drug Drug Interaction of BI 201335 and Tenofovir
Condition: HIV Infections
Intervention: Drug: tenofovir/BI 201335
16 Terminated Study of MK-1972 in Human Immunodeficiency Virus (HIV)-1 Infected Participants Who Have Not Previously Received Antiretroviral Therapy (MK-1972-003)
Condition: HIV-1 Infection
Interventions: Drug: MK-1972;   Drug: Placebo to MK-1972
17 Terminated Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With Ccr5 Tropic HIV 1
Condition: HIV-1
Interventions: Drug: Maraviroc;   Drug: Emtricitabine/tenofovir
18 Unknown  Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder
Condition: HIV Associated Neurocognitive Disorder
Interventions: Drug: Fluconazole;   Drug: Paroxetine;   Drug: Paroxetine and Fluconazole;   Drug: Placebo
19 Recruiting Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients
Conditions: HIV-1 Infection;   AIDS
Interventions: Drug: Maraviroc (Celsentri);   Drug: Placebo
20 Completed Evaluation of a New HIV Prevention Intervention for Black Bisexually-active Men
Conditions: Bisexually-active Men;   at Risk for HIV
Interventions: Behavioral: RISE life coaching intervention;   Behavioral: HIV Counseling

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Indicates status has not been verified in more than two years